Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1Tumor Virus Infections 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Penile Neoplasms 1Lung Neoplasms 1Head and Neck Neoplasms 1HIV Infections 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1AIDS-Related Complex 1

Interventions

Observation 2Watchful Waiting 1Trichloroacetic Acid 1Therapeutics 1Rapid Diagnostic Tests 1Light Coagulation 1Laser Therapy 1Isotretinoin 1Interferon alpha-2 1Imiquimod 1Fluorouracil 1Enzyme-Linked Immunosorbent Assay 1Electrocoagulation 1Anti-HIV Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Acquired Immunodeficiency Syndrome × Isotretinoin × Gastrointestinal × Clear all
NCT00000764 2021-10-28

Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
98 enrolled
Gastrointestinal

Acquired Immunodeficiency Syndrome, AIDS-Related Complex, Anus Neoplasms, Tumor Virus Infections, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡